Celularity begins dosing in Phase I/II Covid-19 trial of CYNK-001
The Phase I/II trial is enroling patients with Covid-19 in the US. Credit: Tumisu from Pixabay.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinueLearn more